Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

BUY
$62.68 - $95.05 $188 - $285
3 Added 21.43%
17 $1,000
Q1 2023

May 10, 2023

BUY
$47.19 - $70.77 $141 - $212
3 Added 27.27%
14 $0
Q4 2022

Feb 01, 2023

BUY
$30.35 - $53.15 $151 - $265
5 Added 83.33%
11 $0
Q3 2022

Nov 03, 2022

BUY
$31.97 - $49.37 $159 - $246
5 Added 500.0%
6 $0
Q2 2022

Aug 09, 2022

SELL
$35.61 - $76.23 $213 - $457
-6 Reduced 85.71%
1 $0
Q1 2022

Apr 22, 2022

BUY
$57.56 - $82.54 $402 - $577
7 New
7 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Disciplined Investments, LLC Portfolio

Follow Disciplined Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investments, LLC with notifications on news.